ADMINISTRATIVE PRACTICES SUPPLEMENT TO THE NIH GUIDELINES FOR RESEARCH INVOLVING RECOMBINANT DNA MOLECULES: POLICIES AND ADMINISTRATIVE PROCEDURES FOR RECOMBINANT DNA RESEARCH SUBJECT TO THE NIH GUIDELINES [PDF]
National Institute of General Medical Sciences (United States). Office of Recombinant DNA Activities
core
CpxR and LrhA coordinate the regulation of Xenocoumacin 1 biosynthesis, flagellar assembly, and chemotaxis in <i>Xenorhabdus nematophila</i>. [PDF]
Han Y +9 more
europepmc +1 more source
Our research unveiled a regulatory paradigm wherein TRIM25 orchestrates the ubiquitin‐mediated degradation of UGDH. UGDH modulates the protein stability of TJP1 by regulating O‐GlcNAcylation levels, effectively impeding the metastasis of ccRCC. Our insights elevate UGDH to a pivotal biomarker and tumor suppressor, marking the first demonstration that ...
Xiaolin Chen +13 more
wiley +1 more source
Prenatal Gene Transfer: Scientific, Medical, and Ethical Issues: A Report of the Recombinant DNA Advisory Committee [PDF]
National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee
core
A rapid yeast-based reverse genetics system reveals SARS-CoV-2 Omicron BA.2.86 variant spreads faster than Omicron JN.1 variant in primary human nasal and bronchial epithelial airway cultures. [PDF]
Xu J +11 more
europepmc +1 more source
ANKS1B in the nucleus accumbens plays a critical role in the transition from controlled to escalated cocaine intake. Mechanistically, ANKS1B interacts with CBP to epigenetically suppress FoxO3 through H3K27 acetylation. The ANKS1B‐CBP‐FoxO3 signaling cascade presents a novel theraputic target for the treatment of cocaine addiction.
Liping Yang +15 more
wiley +1 more source
Recombinant DNA Advisory Committee (RAC): 91st meeting of the NIH RAC [PDF]
National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee [RAC]
core
A multifunctional nanoagonist (cDZ@IP) enables nano‐metabolite–driven multimodal activation of the STING pathway and enhanced immune recognition, achieving potent antitumor immunity and suppressing tumor growth and metastasis. This strategy highlights the rational design of therapeutic metabolites and establishes a new paradigm bridging nanomedicine ...
Kepeng Hu +17 more
wiley +1 more source
Recombinant DNA Advisory Committee (RAC): meeting agenda September 19-20, 2002 [PDF]
National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee [RAC]
core
A designed peptide disrupting viral protease cleavage restores cGAS-DNA phase separation and type I interferon responses. [PDF]
Yin H, Zhao Z, Wang H, Li X.
europepmc +1 more source

